449 related articles for article (PubMed ID: 1327566)
1. Apoptosis induced by anticancer drugs.
Hickman JA
Cancer Metastasis Rev; 1992 Sep; 11(2):121-39. PubMed ID: 1327566
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.
Solary E; Bertrand R; Pommier Y
Leuk Lymphoma; 1994 Sep; 15(1-2):21-32. PubMed ID: 7858500
[TBL] [Abstract][Full Text] [Related]
3. The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system.
Cidlowski JA; King KL; Evans-Storms RB; Montague JW; Bortner CD; Hughes FM
Recent Prog Horm Res; 1996; 51():457-90; discussion 490-1. PubMed ID: 8701091
[TBL] [Abstract][Full Text] [Related]
4. [Cytotoxic action of alkylating agents in human tumor cells and its relationship to apoptosis].
Ikenaga M
Gan To Kagaku Ryoho; 1994 Apr; 21(5):596-601. PubMed ID: 8154884
[TBL] [Abstract][Full Text] [Related]
5. Effect of protease inhibitors on early events of apoptosis.
Hara S; Halicka HD; Bruno S; Gong J; Traganos F; Darzynkiewicz Z
Exp Cell Res; 1996 Mar; 223(2):372-84. PubMed ID: 8601414
[TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerases as anticancer drug targets: from the laboratory to the clinic.
Holden JA
Curr Med Chem Anticancer Agents; 2001 May; 1(1):1-25. PubMed ID: 12678768
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced apoptosis of lymphoid cells.
Schwartzman RA; Cidlowski JA
Int Arch Allergy Immunol; 1994 Dec; 105(4):347-54. PubMed ID: 7981603
[TBL] [Abstract][Full Text] [Related]
8. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
9. Cell death in response to antimetabolites directed at thymidylate synthase.
Barbour KW; Berger FG
Cancer Chemother Pharmacol; 2008 Feb; 61(2):189-201. PubMed ID: 17396263
[TBL] [Abstract][Full Text] [Related]
10. [Anti-tumor activities of steroids--lessons from microarray analysis].
Miyashita T; Oshida T
Nihon Rinsho; 2008 Jan; 66(1):89-93. PubMed ID: 18186254
[TBL] [Abstract][Full Text] [Related]
11. Characterization of DNA fragmentation events caused by genotoxic and non-genotoxic agents.
Ploski JE; Aplan PD
Mutat Res; 2001 Feb; 473(2):169-80. PubMed ID: 11166035
[TBL] [Abstract][Full Text] [Related]
12. Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death.
Calderón-Montaño JM; Burgos-Morón E; Orta ML; Pastor N; Perez-Guerrero C; Austin CA; Mateos S; López-Lázaro M
Pharmacol Rep; 2012; 64(6):1515-25. PubMed ID: 23406762
[TBL] [Abstract][Full Text] [Related]
13. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide-regulated apoptosis in S49 cells.
Caron-Leslie LA; Evans RB; Cidlowski JA
FASEB J; 1994 Jun; 8(9):639-45. PubMed ID: 8005391
[TBL] [Abstract][Full Text] [Related]
15. Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin.
Huang X; Okafuji M; Traganos F; Luther E; Holden E; Darzynkiewicz Z
Cytometry A; 2004 Apr; 58(2):99-110. PubMed ID: 15057963
[TBL] [Abstract][Full Text] [Related]
16. The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity.
Swift LP; Cutts SM; Nudelman A; Levovich I; Rephaeli A; Phillips DR
Cancer Chemother Pharmacol; 2008 Apr; 61(5):739-49. PubMed ID: 17594094
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes.
da Silva CP; de Oliveira CR; da Conceição M; de Lima P
Biochem Pharmacol; 1996 May; 51(10):1331-40. PubMed ID: 8787549
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis: molecular mechanisms and implications for cancer chemotherapy.
Guchelaar HJ; Vermes A; Vermes I; Haanen C
Pharm World Sci; 1997 Jun; 19(3):119-25. PubMed ID: 9259027
[TBL] [Abstract][Full Text] [Related]
19. [Poisons of DNA topoisomerases I and II].
Charcosset JY; Soues S; Laval F
Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
[TBL] [Abstract][Full Text] [Related]
20. Physician Education: Apoptosis.
Kataoka S; Tsuruo T
Oncologist; 1996; 1(6):399-401. PubMed ID: 10388021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
